Zhejiang Wecome Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Zhejiang Wecome Pharmaceutical has a total shareholder equity of CN¥1.4B and total debt of CN¥332.0M, which brings its debt-to-equity ratio to 24.3%. Its total assets and total liabilities are CN¥1.8B and CN¥471.0M respectively.
Key information
24.3%
Debt to equity ratio
CN¥332.01m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥324.27m |
| Equity | CN¥1.36b |
| Total liabilities | CN¥471.01m |
| Total assets | CN¥1.84b |
Recent financial health updates
No updates
Recent updates
Subdued Growth No Barrier To Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) With Shares Advancing 39%
Oct 09
Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) Investors Are Less Pessimistic Than Expected
Aug 02Subdued Growth No Barrier To Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) With Shares Advancing 29%
Mar 08Financial Position Analysis
Short Term Liabilities: 300878's short term assets (CN¥788.5M) exceed its short term liabilities (CN¥152.7M).
Long Term Liabilities: 300878's short term assets (CN¥788.5M) exceed its long term liabilities (CN¥318.3M).
Debt to Equity History and Analysis
Debt Level: 300878's net debt to equity ratio (0.6%) is considered satisfactory.
Reducing Debt: 300878's debt to equity ratio has reduced from 28.9% to 24.3% over the past 5 years.
Debt Coverage: 300878's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 300878's interest payments on its debt are well covered by EBIT.